Caliway to Present CBL-514 Phase 2 Study Results for Subcutaneous Fat Reduction at IMCAS 2024

Caliway Biopharmaceuticals announced that the company will present at the 25th IMCAS World Congress on 1-3 February 2024 in Paris, France.